These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36943359)

  • 1. Patient Experiences With Prescription Cannabinoids in Germany: Protocol for a Mixed Methods, Exploratory, and Anonymous Web-Based Survey.
    Fischer JM; Kandil FI; Karst M; Zager LS; Jeitler M; Kugler F; Fitzner F; Michalsen A; Kessler CS
    JMIR Res Protoc; 2023 Mar; 12():e38814. PubMed ID: 36943359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients.
    Fischer JM; Kandil FI; Katsarova E; Zager LS; Jeitler M; Kugler F; Fitzner F; Murthy V; Hanslian E; Wendelmuth C; Michalsen A; Karst M; Kessler CS
    Front Med (Lausanne); 2023; 10():1196160. PubMed ID: 38143449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study.
    Mansell H; Quinn D; Kelly LE; Szafron M; Alcorn J
    JMIR Res Protoc; 2021 Oct; 10(10):e31281. PubMed ID: 34661540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review.
    Mohiuddin MM; Mizubuti G; Haroutounian S; Smith S; Campbell F; Park R; Gilron I
    JMIR Res Protoc; 2019 Jan; 8(1):e11637. PubMed ID: 30688655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of a standardized survey on the medical use of cannabis products in the German-speaking area].
    Schnelle M; Grotenhermen F; Reif M; Gorter RW
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():28-36. PubMed ID: 10575286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in Germany.
    Kusch M; Labouvie H; Schiewer V; Talalaev N; Cwik JC; Bussmann S; Vaganian L; Gerlach AL; Dresen A; Cecon N; Salm S; Krieger T; Pfaff H; Lemmen C; Derendorf L; Stock S; Samel C; Hagemeier A; Hellmich M; Leicher B; Hültenschmidt G; Swoboda J; Haas P; Arning A; Göttel A; Schwickerath K; Graeven U; Houwaart S; Kerek-Bodden H; Krebs S; Muth C; Hecker C; Reiser M; Mauch C; Benner J; Schmidt G; Karlowsky C; Vimalanandan G; Matyschik L; Galonska L; Francke A; Osborne K; Nestle U; Bäumer M; Schmitz K; Wolf J; Hallek M
    BMC Health Serv Res; 2022 Apr; 22(1):543. PubMed ID: 35459202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Utilization of Preventive Services in the 55-Plus Age Group: Protocol for a Mixed Methods Study.
    Hrudey I; Minow A; Walter S; March S; Swart E; Stallmann C
    JMIR Res Protoc; 2022 Jan; 11(1):e33512. PubMed ID: 35019847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Quality-of-Life Evaluation Study Assessing Health-Related Quality of Life in Patients Receiving Medicinal Cannabis (the QUEST Initiative): Protocol for a Longitudinal Observational Study.
    Tait MA; Costa DSJ; Campbell R; Norman R; Schug S; Rutherford C
    JMIR Res Protoc; 2021 Nov; 10(11):e32327. PubMed ID: 34821570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids for fibromyalgia.
    Walitt B; Klose P; Fitzcharles MA; Phillips T; Häuser W
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011694. PubMed ID: 27428009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic potential of cannabis and cannabinoids.
    Grotenhermen F; Müller-Vahl K
    Dtsch Arztebl Int; 2012 Jul; 109(29-30):495-501. PubMed ID: 23008748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.
    Melton H; Meader N; Dale H; Wright K; Jones-Diette J; Temple M; Shah I; Lovell K; McMillan D; Churchill R; Barbui C; Gilbody S; Coventry P
    Health Technol Assess; 2020 Sep; 24(43):1-312. PubMed ID: 32924926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes.
    Modaresi F; Talachian K
    Pharmaceut Med; 2022 Dec; 36(6):387-400. PubMed ID: 36357543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and treatment barriers to persistent somatic symptoms in primary care - representative survey with physicians.
    Lehmann M; Pohontsch NJ; Zimmermann T; Scherer M; Löwe B
    BMC Fam Pract; 2021 Apr; 22(1):60. PubMed ID: 33794776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.